Miller Drug Inc is an authorized DME supplier for medicare equipments and products.
Miller Drug Inc is a Community/Retail Pharmacy in Redfield, South Dakota. It is located at 1010 W 1st St Ste 2, Redfield and it's customer support contact number is 605-472-1810. The authorized person of Miller Drug Inc is Dillon Kjerstad who is Owner of the pharmacy and his contact number is 605-859-2843. Active license number of Miller Drug Inc is 1000057 for Community/Retail Pharmacy in South Dakota. Miller Drug Inc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance. Miller Drug Inc is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
Miller Drug Inc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name:
Miller Drug Inc
Type:
Community/Retail Pharmacy
Location:
1010 W 1st St Ste 2, Redfield, South Dakota, 57469-1503
Phone:
605-472-1810
Fax:
605-472-1812
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name:
Dillon Kjerstad
Position:
Owner
Contact Number:
605-859-2843
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number:
1669468906
NPI Enumeration Date:
22 Sep, 2005
NPI Last Update On:
30 Nov, 2023
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Miller Drug Inc are as mentioned below.
Specialization
License Number
State
Status
Community/Retail Pharmacy
1000057
South Dakota
Primary
Pharmacy
Secondary
Clinic Pharmacy
Secondary
Long Term Care Pharmacy
1000057
South Dakota
Secondary
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
1669468906
Medicaid
South Dakota
096790400
Medicaid
Minnesota
Medicare Enrollment:
Miller Drug Inc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
PAC ID:
Enrollment ID:
Org Name
Medicare Entity Type
5395864722
O20100930027440
Miller Drug Inc
DME SUPPLIER - PHARMACY
Products Available:
Miller Drug Inc has following products available for sale under medicare.
Products
Blood Glucose Monitors & Supplies: Mail Order
Blood Glucose Monitors & Supplies: Non-mail Order
Canes & Crutches
Commodes, Urinals, & Bedpans
Diabetic Shoes & Inserts: Custom Fabricated
Diabetic Shoes & Inserts: Prefabricated
Heat & Cold Applications
Nebulizer Equipment & Supplies
Orthoses: Off-the-shelf
Ostomy Supplies
Walkers
Wheelchairs & Accessories: Standard Manual
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 878, Philip, South Dakota
Zip:
57567-0878
Phone Number:
605-472-1810
Fax Number:
605-472-1812
Patients can reach Miller Drug Inc at 1010 W 1st St Ste 2, Redfield, South Dakota or can call on customer care at 605-472-1810.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.